Your browser doesn't support javascript.
loading
Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge, Samantha; Lawler, Nathan G; Gray, Nicola; Masuda, Reika; Nitschke, Philipp; Whiley, Luke; Bong, Sze-How; Yeap, Bu B; Dwivedi, Girish; Spraul, Manfred; Schaefer, Hartmut; Gil-Redondo, Rubén; Embade, Nieves; Millet, Oscar; Holmes, Elaine; Wist, Julien; Nicholson, Jeremy K.
Afiliação
  • Lodge S; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Lawler NG; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Gray N; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Masuda R; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Nitschke P; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Whiley L; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Bong SH; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Yeap BB; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Dwivedi G; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Spraul M; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Schaefer H; Australian National Phenome Center, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
  • Gil-Redondo R; Medical School, University of Western Australia, Perth, WA 6150, Australia.
  • Embade N; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, WA 6150, Australia.
  • Millet O; Medical School, University of Western Australia, Perth, WA 6150, Australia.
  • Holmes E; Department of Cardiology, Fiona Stanley Hospital, Perth, WA 6150, Australia.
  • Wist J; Bruker Biospin GmbH, 76287 Rheinstetten, Germany.
  • Nicholson JK; Bruker Biospin GmbH, 76287 Rheinstetten, Germany.
Int J Mol Sci ; 24(14)2023 Jul 18.
Article em En | MEDLINE | ID: mdl-37511373
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Suíça